Medexus Pharmaceuticals Inc (TSE:MDP) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Medexus Pharmaceuticals Inc has announced a conference call for June 26, 2024, to discuss its fourth fiscal quarter and full fiscal year performance, with the financial statements to be released post-market on June 25. The call will attract investors from Canada, the U.S., and internationally, with live and replay options available via webcast and phone. Medexus, known for its focus on rare disease treatments and specialty pharmaceuticals, runs a strong North American commercial platform.
For further insights into TSE:MDP stock, check out TipRanks’ Stock Analysis page.
